AKR1D1 and hepatocellular carcinoma: Consistent with these findings, AKR1D1 knockdown increased the protein expression of AKT1 and mTOR in both human hepatoma cell lines, indicative of alterations in the activation of the insulin signalling cascade (Fig. 4c and d).